{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:35:18Z","timestamp":1787495718990,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009104","name":"Department of Health Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009053","name":"DBT\/Wellcome Trust India Alliance","doi-asserted-by":"publisher","award":["IA\/CPHI\/17\/1\/503333"],"award-info":[{"award-number":["IA\/CPHI\/17\/1\/503333"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.labinv.2025.104201","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T02:28:48Z","timestamp":1748485728000},"page":"104201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Integrative Genetic and Transcriptomic Subtyping Improves Prognosis Prediction in B-Lineage Acute Lymphoblastic Leukemia"],"prefix":"10.1016","volume":"105","author":[{"given":"Mercilena","family":"Benjamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avanish Kumar","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Thukral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3903-7252","authenticated-orcid":false,"given":"Jayanth Kumar","family":"Palanichamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Bakhshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepam","family":"Pushpam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish Prasad","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Tanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1123-338X","authenticated-orcid":false,"given":"Amar Ranjan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-8702","authenticated-orcid":false,"given":"Anita","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.labinv.2025.104201_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J"},{"issue":"5","key":"10.1016\/j.labinv.2025.104201_bib2","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3390\/ijms23052755","article-title":"Genetic biomarkers and their clinical implications in B-cell acute lymphoblastic leukemia in children","volume":"23","author":"Lejman","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.labinv.2025.104201_bib3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.mayocp.2016.09.010","article-title":"Adult acute lymphoblastic leukemia","volume":"91","author":"Paul","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"17","key":"10.1016\/j.labinv.2025.104201_bib4","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.3390\/jcm10173792","article-title":"Biologic and therapeutic implications of genomic alterations in acute lymphoblastic leukemia","volume":"10","author":"Iacobucci","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.labinv.2025.104201_bib5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/bloodadvances.2021005634","article-title":"Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001","volume":"6","author":"Tran","year":"2022","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.labinv.2025.104201_bib6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1186\/s12885-021-08635-5","article-title":"Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia","volume":"21","author":"Walter","year":"2021","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.labinv.2025.104201_bib7","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.3390\/cancers12102815","article-title":"DUX hunting-clinical features and diagnostic challenges associated with DUX4-rearranged leukaemia","volume":"12","author":"Rehn","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.labinv.2025.104201_bib8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.labinv.2025.104201_bib9","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.2020010144","article-title":"Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL","volume":"138","author":"Paietta","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.labinv.2025.104201_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semcancer.2020.10.013","article-title":"The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities","volume":"84","author":"Tran","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"10.1016\/j.labinv.2025.104201_bib11","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","article-title":"The genomic landscape of pediatric acute lymphoblastic leukemia","volume":"54","author":"Brady","year":"2022","journal-title":"Nat Genet"},{"issue":"15","key":"10.1016\/j.labinv.2025.104201_bib12","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.labinv.2025.104201_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.labinv.2025.104201_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.labinv.2025.104201_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"issue":"10","key":"10.1016\/j.labinv.2025.104201_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis for sequence count data","volume":"11","author":"Anders","year":"2010","journal-title":"Genome Biol"},{"issue":"6","key":"10.1016\/j.labinv.2025.104201_bib17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.labinv.2025.104201_bib18","article-title":"FusionCatcher\u2014a tool for finding somatic fusion genes in paired-end RNA-sequencing data","author":"Nicorici","year":"2014","journal-title":"Preprint"},{"issue":"1","key":"10.1016\/j.labinv.2025.104201_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2011-12-1-r6","article-title":"Identification of fusion genes in breast cancer by paired-end RNA-sequencing","volume":"12","author":"Edgren","year":"2011","journal-title":"Genome Biol"},{"issue":"2","key":"10.1016\/j.labinv.2025.104201_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","article-title":"Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia","volume":"22","author":"Roberts","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.labinv.2025.104201_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.labinv.2025.104201_bib22","first-page":"1741","article-title":"MD-ALL: an integrative platform for molecular diagnosis of B-acute lymphoblastic leukemia","volume":"109","author":"Hu","year":"2024","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.labinv.2025.104201_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13063-022-06033-1","article-title":"Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India","volume":"23","author":"Das","year":"2022","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.labinv.2025.104201_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/leu.2009.257","article-title":"Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000","volume":"24","author":"M\u00f6ricke","year":"2010","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.labinv.2025.104201_bib25","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica"},{"issue":"29","key":"10.1016\/j.labinv.2025.104201_bib26","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1200\/JCO.23.02238","article-title":"Genomic determinants of outcome in acute lymphoblastic leukemia","volume":"42","author":"Chang","year":"2024","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.labinv.2025.104201_bib27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/ejh.14164","article-title":"Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis","volume":"112","author":"Podgorica","year":"2024","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.labinv.2025.104201_bib28","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41375-022-01557-6","article-title":"UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment","volume":"36","author":"Bastian","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.labinv.2025.104201_bib29","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.labinv.2025.104201_bib30","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood.2021011921","article-title":"Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1\/2 mutations","volume":"139","author":"Yasuda","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.labinv.2025.104201_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2018-10-882142","article-title":"PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome","volume":"133","author":"Passet","year":"2019","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.labinv.2025.104201_bib32","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1182\/blood.2022015444","article-title":"Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia","volume":"139","author":"Kimura","year":"2022","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.labinv.2025.104201_bib33","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.2021014723","article-title":"Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL","volume":"139","author":"Passet","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.labinv.2025.104201_bib34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/cncr.34606","article-title":"Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia","volume":"129","author":"Yu","year":"2023","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.labinv.2025.104201_bib35","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000883","article-title":"Genetic subtypes and outcome of patients aged 1 to 45 years old with acute lymphoblastic leukemia in the NOPHO ALL2008 trial","volume":"7","author":"Nor\u00e9n-Nystr\u00f6m","year":"2023","journal-title":"Hemasphere"},{"issue":"4","key":"10.1016\/j.labinv.2025.104201_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2021.101331","article-title":"Has Ph-like ALL Superseded Ph+ ALL as the least favorable subtype?","volume":"34","author":"Tran","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"issue":"8","key":"10.1016\/j.labinv.2025.104201_bib37","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1016\/j.clml.2022.03.007","article-title":"Clinico-hematological and outcome profile of pediatric B-other-ALL and BCR::ABL1-like pre-B-ALL: an integrated genomic study from North India","volume":"22","author":"Peyam","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.labinv.2025.104201_bib38","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3390\/cancers16061164","article-title":"PAX5 alterations in a consecutive childhood B-cell acute lymphoblastic leukemia cohort treated using the ALL IC-BFM 2009 protocol","volume":"16","author":"\u010crepin\u0161ek","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.labinv.2025.104201_bib39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/2643-3230.BCD-20-0229","article-title":"Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy","volume":"2","author":"Jeha","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"25","key":"10.1016\/j.labinv.2025.104201_bib40","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/blood-2016-12-758979","article-title":"Targetable kinase gene fusions in high-risk B-ALL: a study from the Children\u2019s Oncology Group","volume":"129","author":"Reshmi","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.labinv.2025.104201_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000053","article-title":"Advances in B-cell precursor acute lymphoblastic leukemia genomics","volume":"2","author":"Schwab","year":"2018","journal-title":"Hemasphere"},{"issue":"3","key":"10.1016\/j.labinv.2025.104201_bib42","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.18632\/oncotarget.13492","article-title":"Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia","volume":"8","author":"Boer","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.labinv.2025.104201_bib43","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","article-title":"High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults","volume":"35","author":"Roberts","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104201_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood.2023023153","article-title":"How I treat Philadelphia chromosome-like acute lymphoblastic leukemia in children, adolescents, and young adults","volume":"145","author":"Tran","year":"2025","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.labinv.2025.104201_bib45","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s11684-022-0944-z","article-title":"FGF13 suppresses acute myeloid leukemia by regulating bone marrow niches","volume":"16","author":"Li","year":"2022","journal-title":"Front Med"},{"issue":"11","key":"10.1016\/j.labinv.2025.104201_bib46","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1080\/15384047.2020.1824512","article-title":"FGF13 interaction with SHCBP1 activates AKT-GSK3\u03b1\/\u03b2 signaling and promotes the proliferation of A549 cells","volume":"21","author":"Lu","year":"2020","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.labinv.2025.104201_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2023.08.040","article-title":"FGF13A interacts with NPM1 and UBF and inhibits the invasion of bladder cancer cells","volume":"678","author":"Han","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.labinv.2025.104201_bib48","first-page":"17","article-title":"Multiple functions of TBCK protein in neurodevelopment disorders and tumors","volume":"21","author":"Wu","year":"2021","journal-title":"Oncol Lett"},{"issue":"14","key":"10.1016\/j.labinv.2025.104201_bib49","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.3390\/ijms20143540","article-title":"MiR-1208 increases the sensitivity to cisplatin by targeting TBCK in renal cancer cells","volume":"20","author":"Kim","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.labinv.2025.104201_bib50","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.3892\/or.2016.5096","article-title":"Gene fusions AHRR-NCOA2, NCOA2-ETV4, ETV4-AHRR, P4HA2-TBCK, and TBCK-P4HA2 resulting from the translocations t(5;8;17)(p15;q13;q21) and t(4;5)(q24;q31) in a soft tissue angiofibroma","volume":"36","author":"Panagopoulos","year":"2016","journal-title":"Oncol Rep"},{"issue":"6","key":"10.1016\/j.labinv.2025.104201_bib51","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3324\/haematol.2020.247973","article-title":"Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913","volume":"106","author":"Chiaretti","year":"2021","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.labinv.2025.104201_bib52","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.3324\/haematol.2018.214353","article-title":"CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia","volume":"104","author":"Schinnerl","year":"2019","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.labinv.2025.104201_bib53","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.3324\/haematol.2020.250423","article-title":"DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch","volume":"106","author":"Novakova","year":"2021","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.labinv.2025.104201_bib54","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/bloodadvances.2022009179","article-title":"Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing","volume":"7","author":"Migita","year":"2023","journal-title":"Blood Adv"},{"issue":"23","key":"10.1016\/j.labinv.2025.104201_bib55","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1182\/bloodadvances.2021004895","article-title":"Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.labinv.2025.104201_bib56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41408-024-01099-3","article-title":"Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia","volume":"14","author":"Schinnerl","year":"2024","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.labinv.2025.104201_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1023606","article-title":"PAX5 alterations in B-cell acute lymphoblastic leukemia","volume":"12","author":"Jia","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.labinv.2025.104201_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104224","article-title":"PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120","volume":"83","author":"Fazio","year":"2022","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.labinv.2025.104201_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30514","article-title":"Acute lymphoblastic leukemia with infrequent ARID1B::ZNF384 gene fusion simulating multifocal osteomyelitis","volume":"70","author":"Long","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.labinv.2025.104201_bib60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1073\/pnas.1717125115","article-title":"Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.labinv.2025.104201_bib61","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.semdp.2023.04.003","article-title":"Emerging molecular subtypes and therapies in acute lymphoblastic leukemia","volume":"40","author":"Davis","year":"2023","journal-title":"Semin Diagn Pathol"},{"issue":"11","key":"10.1016\/j.labinv.2025.104201_bib62","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/pbc.26116","article-title":"Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B\/ZNF384 gene fusion","volume":"63","author":"Shago","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.labinv.2025.104201_bib63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","article-title":"Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia","volume":"8","author":"Liu","year":"2016","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.labinv.2025.104201_bib64","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3324\/haematol.2016.151035","article-title":"ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype","volume":"102","author":"Hirabayashi","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.labinv.2025.104201_bib65","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/2643-3230.BCD-19-0080","article-title":"Targeting MEF2D-fusion oncogenic transcriptional circuitries in B-cell precursor acute lymphoblastic leukemia","volume":"1","author":"Tsuzuki","year":"2020","journal-title":"Blood Cancer Discov"},{"issue":"8","key":"10.1016\/j.labinv.2025.104201_bib66","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/cts.13535","article-title":"The expanding universe of NUTM1 fusions in pediatric cancer","volume":"16","author":"Charlab","year":"2023","journal-title":"Clin Transl Sci"},{"issue":"10","key":"10.1016\/j.labinv.2025.104201_bib67","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.3324\/haematol.2018.206961","article-title":"NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2","volume":"104","author":"Hormann","year":"2019","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.labinv.2025.104201_bib68","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1038\/s41375-021-01333-y","article-title":"Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study","volume":"35","author":"Boer","year":"2021","journal-title":"Leukemia"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725001114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725001114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:53:08Z","timestamp":1760133188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683725001114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0023683725001114"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104201","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative Genetic and Transcriptomic Subtyping Improves Prognosis Prediction in B-Lineage Acute Lymphoblastic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104201"}}